Net Cash Provided by (Used in) Financing Activities of DermTech, Inc. from 31 Mar 2017 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
DermTech, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2017 to 31 Mar 2024.
  • DermTech, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $122,000, a 87% decline year-over-year.
  • DermTech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6,079,000, a 563% increase from 2022.
  • DermTech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $917,000, a 100% decline from 2021.
  • DermTech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $230,277,000, a 192% increase from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

DermTech, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $122,000 -$794,000 -87% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q1 2023 $916,000 +$389,000 +74% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2022 $527,000 -$204,751,000 -100% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $205,278,000 +$145,158,000 +241% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q1 2020 $60,120,000 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q2 2019 $10,500* +$10,500 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2019 2020 Q1
Q2 2018 $0 -$145,978,974 -100% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019 2020 Q1
Q2 2017 $145,978,974 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018 2019 Q1

DermTech, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $6,079,000 +$5,162,000 +563% 01 Jan 2023 31 Dec 2023 10-K 29 Feb 2024 2023 FY
2022 $917,000 -$229,360,000 -100% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 $230,277,000 +$151,379,000 +192% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 $78,898,000 +$50,276,000 +176% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
2019 $28,622,000 +$17,494,000 +157% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2022 2021 FY
2018 $11,128,000 -$134,857,833 -92% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2020 2019 FY
2017 $145,985,833 +$145,979,468 01 Apr 2017 31 Mar 2018 10-K 14 Jun 2019 2019 FY
2016 $6,365* 01 Apr 2016 31 Mar 2017 10-K 29 Jun 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.